These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32278882)

  • 1. The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis.
    Melero-Jerez C; Alonso-Gómez A; Moñivas E; Lebrón-Galán R; Machín-Díaz I; de Castro F; Clemente D
    Neurobiol Dis; 2020 Jul; 140():104869. PubMed ID: 32278882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central and peripheral myeloid-derived suppressor cell-like cells are closely related to the clinical severity of multiple sclerosis.
    Ortega MC; Lebrón-Galán R; Machín-Díaz I; Naughton M; Pérez-Molina I; García-Arocha J; Garcia-Dominguez JM; Goicoechea-Briceño H; Vila-Del Sol V; Quintanero-Casero V; García-Montero R; Galán V; Calahorra L; Camacho-Toledano C; Martínez-Ginés ML; Fitzgerald DC; Clemente D
    Acta Neuropathol; 2023 Aug; 146(2):263-282. PubMed ID: 37243699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mir-223 regulates the number and function of myeloid-derived suppressor cells in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Cantoni C; Cignarella F; Ghezzi L; Mikesell B; Bollman B; Berrien-Elliott MM; Ireland AR; Fehniger TA; Wu GF; Piccio L
    Acta Neuropathol; 2017 Jan; 133(1):61-77. PubMed ID: 27704281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis.
    Camacho-Toledano C; Machín-Díaz I; Calahorra L; Cabañas-Cotillas M; Otaegui D; Castillo-Triviño T; Villar LM; Costa-Frossard L; Comabella M; Midaglia L; García-Domínguez JM; García-Arocha J; Ortega MC; Clemente D
    J Neuroinflammation; 2022 Nov; 19(1):277. PubMed ID: 36403026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
    Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
    PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Myeloid-Derived Suppressor Cells in Multiple Sclerosis and Its Animal Model.
    Jiang Q; Duan J; Van Kaer L; Yang G
    Aging Dis; 2024 May; 15(3):1329-1343. PubMed ID: 37307825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloid-derived suppressor cells support remyelination in a murine model of multiple sclerosis by promoting oligodendrocyte precursor cell survival, proliferation, and differentiation.
    Melero-Jerez C; Fernández-Gómez B; Lebrón-Galán R; Ortega MC; Sánchez-de Lara I; Ojalvo AC; Clemente D; de Castro F
    Glia; 2021 Apr; 69(4):905-924. PubMed ID: 33217041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability.
    Moliné-Velázquez V; Ortega MC; Vila del Sol V; Melero-Jerez C; de Castro F; Clemente D
    Neurobiol Dis; 2014 Jul; 67():149-64. PubMed ID: 24709559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis.
    Moliné-Velázquez V; Cuervo H; Vila-Del Sol V; Ortega MC; Clemente D; de Castro F
    Brain Pathol; 2011 Nov; 21(6):678-91. PubMed ID: 21507122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells.
    Elliott DM; Singh N; Nagarkatti M; Nagarkatti PS
    Front Immunol; 2018; 9():1782. PubMed ID: 30123217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frontline Science: Induction of experimental autoimmune encephalomyelitis mobilizes Th17-promoting myeloid derived suppressor cells to the lung.
    Glenn JD; Liu C; Whartenby KA
    J Leukoc Biol; 2019 May; 105(5):829-841. PubMed ID: 30762897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-derived suppressor cells prevent disruption of the gut barrier, preserve microbiota composition, and potentiate immunoregulatory pathways in a rat model of experimental autoimmune encephalomyelitis.
    Radojević D; Bekić M; Gruden-Movsesijan A; Ilić N; Dinić M; Bisenić A; Golić N; Vučević D; Đokić J; Tomić S
    Gut Microbes; 2022; 14(1):2127455. PubMed ID: 36184742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis.
    Melero-Jerez C; Suardíaz M; Lebrón-Galán R; Marín-Bañasco C; Oliver-Martos B; Machín-Díaz I; Fernández Ó; de Castro F; Clemente D
    Neurobiol Dis; 2019 Jul; 127():13-31. PubMed ID: 30798007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of relapsing-remitting and chronic forms of experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Berard JL; Wolak K; Fournier S; David S
    Glia; 2010 Mar; 58(4):434-45. PubMed ID: 19780195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TREM2-transduced myeloid precursors mediate nervous tissue debris clearance and facilitate recovery in an animal model of multiple sclerosis.
    Takahashi K; Prinz M; Stagi M; Chechneva O; Neumann H
    PLoS Med; 2007 Apr; 4(4):e124. PubMed ID: 17425404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Myeloid-derived Gr-1⁺ CD11b⁺ suppressor cells are involved in immunoregulation of experimental autoimmune encephalomyelitis].
    Wu F; Dang D; Guo J; Li H; Yang K; Zhao D; Guo P; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Aug; 30(8):789-92, 797. PubMed ID: 25108427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue Transglutaminase contributes to experimental multiple sclerosis pathogenesis and clinical outcome by promoting macrophage migration.
    van Strien ME; de Vries HE; Chrobok NL; Bol JGJM; Breve JJP; van der Pol SMP; Kooij G; van Buul JD; Karpuj M; Steinman L; Wilhelmus MM; Sestito C; Drukarch B; Van Dam AM
    Brain Behav Immun; 2015 Nov; 50():141-154. PubMed ID: 26133787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathological findings in rats with experimental allergic encephalomyelitis.
    Dong M; Liu R; Guo L; Li C; Tan G
    APMIS; 2008 Nov; 116(11):972-84. PubMed ID: 19132994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The DC-HIL/syndecan-4 pathway regulates autoimmune responses through myeloid-derived suppressor cells.
    Chung JS; Tamura K; Akiyoshi H; Cruz PD; Ariizumi K
    J Immunol; 2014 Mar; 192(6):2576-84. PubMed ID: 24516197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early axonal damage and progressive myelin pathology define the kinetics of CNS histopathology in a mouse model of multiple sclerosis.
    Recks MS; Stormanns ER; Bader J; Arnhold S; Addicks K; Kuerten S
    Clin Immunol; 2013 Oct; 149(1):32-45. PubMed ID: 23899992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.